GreenbergerP.A.2006. Drug allergy. J. Allergy Clin. Immunol.117(S):464.
2.
RoujeauJ.C.2005. Clinical heterogeneity of drug hypersensitivity. Toxicology209:123.
3.
TasS. and SimonartT.. 2003. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology206:353.
4.
FieldsK.S.PetersenM.J.ChiaoE. and Tristani-FirouziP.. 2005. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J. Drugs Dermatol. 4:510.
5.
CarrollM.C.Yueng-YueK.A.EsterlyN.B. and DroletB.A.. 2001. Drug-induced hypersensitivity syndrome in pediatric patients. Pediatrics108:485.
6.
WolfR.OrionE.MarcosB. and MatzH.. 2005. Life-threatening acute adverse cutaneous drug reactions. Clin. Dermatol.23:171.
7.
GhislainP.D.BodarweA.D.VanderdoncktO.TennstedtD.MarotL. and LachapelleJ.M.. 2004. Drug induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome. Acta Derm. Venereol.84:65.
8.
MichelF.NavellouJ.C.FerraudD.ToussirotE. and WendlingD.. 2005. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis. Joint Bone Spine72:82.
9.
van LeeuwenJ.F.van der HooftC.S.VosL.E.BekkenkM.W.van ZuurenE.J. and StriekerB.H.. 2005. Drug rash with eosinophilia and systemic symptoms (DRESS) attributed to the oral skin-care supplement Imedeen. Ned. Tijdschr. Geneeskd.149:1353.
10.
IchicheM.KieschN. and De BelsD.. 2003. DRESS syndrome associated with HHV-6 reactivation. Eur. J. Intern. Med.14:498.
11.
DescampsV.ValanceA.EdlingerC.FilletA.M.GrossinM.Lebrun-VignesB.BelaichS. and CrickxB.. 2001. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch. Dermatol.137:301.
12.
AkcamF.Z.AygunF.O. and AkkayaV.B.. 2006. DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone. J. Infect.53:51.
13.
CoppolaG.AuricchioG.FedericoR.CarotenutoM. and PascottoA.. 2004. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Epilepsia45:1049.